Price increases and new drugs drive increased expenditures for multiple sclerosis.
Prime Therapeutics LLC, Eagan, MN 55121, USA. jschafer@primetherapeutics.com
Jeremy A
JA
Schafer
Brent W
BW
Gunderson
Patrick P
PP
Gleason
D019985:Benchmarking; D017047:Cost Sharing; D003362:Cost-Benefit Analysis; D017277:Drug Approval; D016527:Drug Costs; D005102:Health Expenditures; D006801:Humans; D009103:Multiple Sclerosis / Q000188:drug therapy*